Search

everythinglearnresearchcommunity

for

Search:↓

Advancements in dermatology are improving diagnosis, treatment options, and patient care.

COVID-19 vaccination is generally safe for people with Hidradenitis Suppurativa.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

This special edition focuses on the unique aspects of treating skin conditions in women, including during pregnancy and in diverse populations like women of color and transgender patients.

The document summarizes important skin care topics for non-specialist doctors, including treatments for skin conditions and the management of skin diseases.

Psoriasis increases annual healthcare costs by $4,044 per patient, with biologic treatments costing significantly more than phototherapy.

Galea fixation is a safe and effective way to remove bald scalp with minimal scarring and reduced stretch-back.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Biologicals are increasingly used in medicine and cosmetics, especially for skin and hair treatments, but more research is needed.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Swiss experts recommend specific guidelines for diagnosing and treating hidradenitis suppurativa to improve patient care.

New treatments for alopecia areata show promise, but no cure exists and responses to treatments vary.

Antiandrogen therapy for hidradenitis suppurativa lacks strong evidence and needs more research.

Patients with alopecia areata feel less regret about treatment decisions when they are involved in the decision-making process.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

New treatments for atopic dermatitis and alopecia areata have been developed using a targeted approach.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Antibiotics and finasteride are very effective for treating pediatric hidradenitis suppurativa.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Botulinum toxin type A may help treat hidradenitis suppurativa.

The congress highlighted concerns about the effectiveness of over-the-counter nail treatments, the link between hair loss and daily care products, and the safety of skin treatments during COVID-19.

Microneedles show promise for improving hair regrowth in alopecia.